Hims & Hers Health
HIMS · NYSE
Bulios Fair Price
$41.02
46.6% upside
Current Price
$27.98
According to Bulios Fair Price, HIMS is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Hims & Hers Health, Inc. is an American company focused on providing telemedicine and digital health services. The company specializes in the areas of healthcare, wellness, and medical consultations through an online platform. Hims & Hers allows patients to consult with doctors and specialists from the comfort of their homes through video calls and online chat. The company also offers the option to order medications and healthcare products online with direct delivery to the patient. Hims & Hers aims to improve access to healthcare and raise awareness of various health issues through its platform and digital services. The company follows the growing trend in telemedicine and digital health care and actively contributes to the modernization and transformation of the healthcare industry. Hims & Hers Health, Inc. (HIMS) shares are an interesting choice for investors who follow the healthcare sector and seek investment opportunities in a company that provides innovative healthcare services through modern technologies.
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Andrew Dudum
Employees
2,442
Headquarters
San Francisco
Upcoming events
Earnings
Upcoming earnings report